Compare Novavax Inc (NVAX) vs RingCentral Inc. Class A Common Stock (RNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs RingCentral Inc. Class A Common Stock — how do they compare? Novavax Inc trades at $12.75 (market cap $1.82B), while RingCentral Inc. Class A Common Stock trades at $79.27 (market cap $6.54B). The key difference: RingCentral Inc. Class A Common Stock is far larger — about 3.6× Novavax Inc's market cap, and RingCentral Inc. Class A Common Stock pays a 0.35% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novavax Inc for 59 Days and RingCentral Inc. Class A Common Stock for 1 Days on average.
| NVAX | RNG | |
|---|---|---|
Market Cap | $1.82B | $6.54B |
Volume | 6,198,505 | 1,543,570 |
Sector | Health | Technology |
52-Week High | $12.75 | $79.82 |
52-Week Low | $6.22 | $24.82 |
Typical Hold Time | 59 Days | 1 Days |
Enterprise Value | $1.39B | $7.60B |
Dividend Yield | — | 0.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $11.01, down 1.87% on the day, with a bullish technical signal from moving averages and a strong buy consensus from analysts (73.9% buy ratings). The company reported a net income of $440.3M in 2025, a significant turnaround from prior losses, though 2026 projections show a return to negative margins. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivots toward its Matrix-M adjuvant platform through partnerships.
The outlook is mixed: near-term catalysts include partnership-driven growth and vaccine approvals, but persistent cash burn and projected 2026 losses pose risks. Investor sentiment is buoyed by recent earnings beats and strategic shifts, yet execution on profitability remains critical for sustained upside.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About RingCentral Inc. Class A Common Stock
RingCentral provides cloud-based business communications and contact center solutions. Its platform combines phone, messaging, video meetings, and customer-service tools.
Read more on RNG →
